GARY E BORODIC, M.D.
Medical Practice at Furnace Brook Pkwy, Quincy, MA
License number
Massachusetts 51271
Category
Medical Practice
Type
Ophthalmology
Address
Address
1261 Furnace Brook Pkwy SUITE 15, Quincy, MA 02169
Phone
(617) 770-0011
(617) 770-0030 (Fax)
(617) 770-0030 (Fax)
Organization information
See more information about GARY E BORODIC at bizstanding.comAssociated Eye PHYS & Surgeons
1261 Furnace Brk Pkwy STE 15, Quincy, MA 02169
Doing business as:
Associated Eye Physicians & Surgeons - Gary E Borodic MD
Site:
Phone:
(617) 770-0011 (Phone)
Description:
The purpose of this atlas is to provide the inexperienced ophthalmologist with a review of basic eyelid surgical procedures, with the use of intraoperative color photographs and black and white illust...
Categories:
Cosmetic & Reconstructive Surgeons, Ophthalmology Physicians & Surgeons, Optometrists, ...
Open Hours:
Mon 08:30 AM-05:00 PM, Tue 08:30 AM-05:00 PM, Wed 08:30 AM-05:00 PM, ...
Specialties:
Cataracts, Glaucoma, Plastic Surgery, ...
In practice since:
1990
Areas served:
Norfolk
Customers served:
Residential
Brands:
Botox, Restylane
Products:
Cosmetic Lid Surgery, Injections, Injections & Fillers, ...
Certifications:
Harvard University, Massachusetts Eye & Ear Infirmary
Additional:
Harvard, Over 20 Years Experience.
Professional information
Dr. Gary E Borodic, Quincy MA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Associated Eye Physicians Srgns
1261 Furnace Brook Pkwy STE 15, Quincy 02169
(617) 770-0011 (Phone)
1261 Furnace Brook Pkwy STE 15, Quincy 02169
(617) 770-0011 (Phone)
Certifications:
Ophthalmology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Associated Eye Physicians Srgns
1261 Furnace Brook Pkwy STE 15, Quincy 02169
Massachusetts General Hospital
55 Fruit St, Boston 02114
Quincy Medical Center
114 Whitwell St, Quincy 02169
1261 Furnace Brook Pkwy STE 15, Quincy 02169
Massachusetts General Hospital
55 Fruit St, Boston 02114
Quincy Medical Center
114 Whitwell St, Quincy 02169
Education:
Medical School
University of Vermont / College of Medicine
Graduated: 1978
Brown Rhode Island Hospital
Massachusetts Eye and Ear Infirmary
Rhode Island Hospital
Harvard U
University of Vermont / College of Medicine
Graduated: 1978
Brown Rhode Island Hospital
Massachusetts Eye and Ear Infirmary
Rhode Island Hospital
Harvard U
Gary E Borodic, Quincy MA
Specialties:
Ophthalmologist
Address:
1261 Furnace Brook Pkwy, Quincy, MA 02169
Education:
University of Vermont, College of Medicine - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Oculoplastics
Rhode Island Hospital - Residency - Internal Medicine
Massachusetts General Hospital - Fellowship - Oculoplastics
Rhode Island Hospital - Residency - Internal Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Extended Length Botulinum Toxin Formulation For Human Or Mammalian Use
US Patent:
2012003, Feb 16, 2012
Filed:
Dec 4, 2009
Appl. No.:
13/132855
Inventors:
Gary E. Borodic - Quincy MA, US
Assignee:
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC. - Quincy MA
International Classification:
A61K 38/16, A61P 25/28, A61P 25/06, A61P 25/00, A61P 13/08, A61P 19/08, A61P 21/00, A61P 25/14, A61P 13/10
US Classification:
424 9464, 514 177
Abstract:
An extended duration pharmaceutical composition including a botulinum neurotoxin, an adhesive agent, and a stabilizing macromolecule. The composition effectively has all the properties to cause chemodenervation through a facial muscle, or other muscle, that predecessor botulinum toxin preparations have had as well as agents which create a fibrotic adhesion on the under surface of facial muscles (or other muscles) to the facial bone (or other bones) so that the facial bone tethers the under surface of the facial muscle, thereby causing fibrosis to the underlying fat pad. The composition can be used to treat various disorders. Methods of modifying facial contour for functional or cosmetic purposes in a human patient are disclosed which involve injecting a therapeutically effective amount of the disclosed compositions. A method of quantifying the extended duration of the compositions is also disclosed.
Submuscular Facial Fixation (Myo-Osseous Fixation) Using Microincision Microscrew Device, Injectable Glues And Adhesives, And Method And Device For Therapy Of Migraine And Related Headaches
US Patent:
2011031, Dec 29, 2011
Filed:
May 17, 2011
Appl. No.:
13/109925
Inventors:
Gary E. Borodic - Quincy MA, US
International Classification:
A61B 17/86, A61B 17/00
US Classification:
606301, 606151
Abstract:
Procedures for altering the surface of the human face or other body parts by tethering muscle origins, extending muscular attachments and origins, and tethering muscles by causing adhesions of facial muscles which are not naturally present using specific methods materials and devices, and procedures for treating headaches by implanting a device through a micro incision in skin is are described. A microincision microscrew device and methods of using the device in surgical procedures is described. The use of a puncture based injection of bioadhesive into a described functional fibrofatty plane on the undersurface and throughout the muscle proper without use of incisional surgery is also described. Osseous bolting and osseous screws fixating soft tissue elevation via deep muscle tethering to facial bone is shown causing suspension of upper, mid, and lower facial soft tissue structures in a method that is adaptable to other body regions. Additionally, the combined use of screws with bioadhesives and single use of injectable bioadhesives are described.
Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing A Hyaluronidase And Methods Of Use
US Patent:
2009032, Dec 31, 2009
Filed:
Oct 11, 2006
Appl. No.:
12/083058
Inventors:
Gary E. Borodic - Quincy MA, US
International Classification:
A61K 39/08, A61P 21/00, A61P 29/00, A61P 25/00
US Classification:
4242391
Abstract:
The present invention provides compositions that contain botulinum toxin and a hyaluronidase, and that lack human or recombinant serum albumin. The present invention also provides methods of administering the pharmaceutical composition to a subject in need thereof.